Related Experiment Video
Updated: May 18, 2026

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
Published on: May 30, 2025
Synthetic cannabinoid intoxication: a case series and review
Carson R Harris1, Ashley Brown
1Emergency Medicine Department, Regions Hospital, Saint Paul, Minnesota, MN 55101, USA.
Synthetic cannabinoid "Spice" products pose health risks, including seizures and hallucinations, necessitating emergency care. While most users recover, legal frameworks for these substances remain unresolved.
Area of Science:
- Toxicology
- Emergency Medicine
- Public Health
Background:
- Synthetic cannabinoid receptor agonists (SCRAs) are increasingly abused by adolescents.
- Chronic SCRA use can lead to addiction and withdrawal symptoms mirroring cannabis.
- Health risks associated with SCRAs have led to bans in several countries.
Observation:
- A 3-month retrospective review of Emergency Department (ED) cases involving "Spice" use.
- Six patients presented to the ED following "Spice" consumption.
- Common symptoms included tachycardia (5/6), hallucinations (2/6), and seizures (2/6).
Findings:
- "Spice" use can precipitate serious medical conditions requiring ED evaluation.
- Seizures and hallucinations were observed in ED patients.
- Most patients were discharged after observation, with no recurrent seizures reported.
Implications:
- Healthcare providers must be aware of "Spice" and its associated clinical presentations for accurate risk assessment.
- The identification and management of SCRA intoxication present challenges.
- The legal status of synthetic cannabinoids in the United States is still evolving, impacting public health strategies.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Toxidromes: Clinical Features
Pharmaceutical Poisoning: Potential Scenarios
Drug Toxicity: Overview
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drug toxicity: Idiosyncratic Reactions

